Date: 2016-03-11
Type of information: Establishment of a new subsidiary in the US
Compound:
Company: Selvita (Poland)
Therapeutic area:
Type agreement: establishment of a new subsidiary in the US
Action mechanism:
Disease:
Details: * On March 11, 2016, Selvita announced that the company has just opened its West Coast US office, located in San Bruno, CA. Selvita has initiated its US operations in September 2015, opening a fully-owned US subsidiary, Selvita Inc., headquartered in Cambridge, MA. Now the company is officially opening its second office, which is dedicated to the support of the ongoing and future projects for business partners from the West Coast of US. The office is located at 1001 Bayhill Drive, in San Bruno, California.
* On September 18, 2015, Selvita announced that the company is establishing its first offices in the United States. Appreciating the importance of the U.S. biotechnology and pharmaceutical market, Selvita decided to come closer to its partners and clients and open a fully-owned US subsidiary, Selvita Inc. The new company will initially have two offices located where the heart of the biotechnology industry beats - in Greater Boston and in the San Francisco Bay areas. The new office located at 485 Massachusetts Ave. in Cambridge, Massachusetts will be the headquarters of Selvita Inc. and responsible for supporting the ongoing and future projects for our business partners from the East Coast, while the office located at 1001 Bayhill Drive, in San Bruno, California will function to support the projects for our partners from the West Coast.
Financial terms:
Latest news:
